Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gliatamin for Depressive Mood in Type 2 Diabetes
NCT03059069Phase 4Recruiting
- Sponsor
- Yonsei University
- Start
- Jun 2016
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of choline alfoscerate in major depressive disorder (MDD), sponsored by Yonsei University. Started Jun 2016; status: recruiting.
02
Drugs
choline alfoscerate
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03059069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03059069.